Mutation of sodium channel SCN3A in a patient with cryptogenic pediatric partial epilepsy

Neuroscience Letters

Volumn 433, Issue 1, 2008, Pages 65-70

  Holland, Katherine D ^a   Kearney, Jennifer A ^b   Glauser, Tracy A ^a   Buck, Gerri ^a   Keddache, Mehdi ^a   Blankston, John R ^c   Glaaser, Ian W ^c   Kass, Robert S ^c   Meisler, Miriam H ^d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Division of Genetic Medicine   (United States)

^c Cincinnati Children Hospital Medical Center ^*  (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Epilepsy; SCN3A; Sodium channels

Indexed keywords

CARBAMAZEPINE; GLUTAMINE; LYSINE; OXCARBAZEPINE; PROTEIN SCN3A; SODIUM CHANNEL; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOGENIC PARTIAL EPILEPSY; FOCAL EPILEPSY; GENE MUTATION; HUMAN; MONOTHERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE FACTORS; AMINO ACID SUBSTITUTION; ANTICONVULSANTS; BRAIN; BRAIN CHEMISTRY; CELL LINE; CHILD, PRESCHOOL; COHORT STUDIES; CONSERVED SEQUENCE; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE; EPILEPSY, COMPLEX PARTIAL; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; SODIUM CHANNELS;

EID: 39149136856     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.12.064     Document Type: Article

References (34)

1. Ceulemans B.P., Claes L.R., and Lagae L.G. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy 5. Pediatr. Neurol. 30 (2004) 236-243
2. Chang C.C., Acharfi S., Wu M.H., Chiang F.T., Wang J.K., Sung T.C., and Chahine M. A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia 1. Cardiovasc. Res. 64 (2004) 268-278
3. Chen Z., Alcayaga C., Suarez-Isla B.A., O'Rourke B., Tomaselli G., and Marban E. A "minimal" sodium channel construct consisting of ligated S5-P-S6 segments forms a toxin-activatable ionophore. J. Biol. Chem. 277 (2002) 24653-24658
4. Cummins T.R., Aglieco F., Renganathan M., Herzog R.I., Dib-Hajj S.D., and Waxman S.G. Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J. Neurosci. 21 (2001) 5952-5961
5. Dichgans M., Freilinger T., Eckstein G., Babini E., Lorenz-Depiereux B., Biskup S., Ferrari M.D., Herzog J., van den Maagdenberg A.M., Pusch M., and Strom T.M. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine 1. Lancet 366 (2005) 371-377
6. Escayg A., Heils A., MacDonald B.T., Haug K., Sander T., and Meisler M.H. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus-and prevalence of variants in patients with epilepsy. Am. J. Hum. Genet 68 (2001) 866-873
7. Escayg A., MacDonald B.T., Meisler M.H., Baulac S., Huberfeld G., An-Gourfinkel I., Brice A., LeGuern E., Moulard B., Chaigne D., Buresi C., and Malafosse A. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet. 24 (2000) 343-345
8. George Jr. A.L. Inherited disorders of voltage-gated sodium channels. J. Clin. Invest. 115 (2005) 1990-1999
9. Gilbert D.L., and Gartside P.S. Factors affecting the yield of pediatric EEGs in clinical practice 1. Clin. Pediatr. (Phila) 41 (2002) 25-32
10. Goldin A.L. Resurgence of sodium channel research 4. Annu. Rev. Physiol. 63 (2001) 871-894
11. Hirose S., Zenri F., Akiyoshi H., Fukuma G., Iwata H., Inoue T., Yonetani M., Tsutsumi M., Muranaka H., Kurokawa T., Hanai T., Wada K., Kaneko S., and Mitsudome A. A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions 3. Ann. Neurol. 47 (2000) 822-826
12. Kanai K., Hirose S., Oguni H., Fukuma G., Shirasaka Y., Miyajima T., Wada K., Iwasa H., Yasumoto S., Matsuo M., Ito M., Mitsudome A., and Kaneko S. Effect of localization of missense mutations in SCN1A on epilepsy phenotype severity 4. Neurology 63 (2004) 329-334
13. Kearney J.A., Plummer N.W., Smith M.R., Kapur J., Cummins T.R., Waxman S.G., Goldin A.L., and Meisler M.H. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities 1. Neuroscience 102 (2001) 307-317
14. Keller D.I., Rougier J.S., Kucera J.P., Benammar N., Fressart V., Guicheney P., Madle A., Fromer M., Schlapfer J., and Abriel H. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations 2. Cardiovasc. Res. 67 (2005) 510-519
15. Kohrman D.C., Smith M.R., Goldin A.L., Harris J., and Meisler M.H. A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting. J. Neurosci. 16 (1996) 5993-5999
16. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 342 (2000) 314-319
17. Lossin C., Rhodes T.H., Desai R.R., Vanoye C.G., Wang D., Carniciu S., Devinsky O., and George Jr. A.L. Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A 2. J. Neurosci. 23 (2003) 11289-11295
18. Lossin C., Wang D.W., Rhodes T.H., Vanoye C.G., and George Jr. A.L. Molecular basis of an inherited epilepsy 1. Neuron 34 (2002) 877-884
19. Meisler M.H., and Kearney J.A. Sodium channel mutations in epilepsy and other neurological disorders 1. J. Clin. Invest. 115 (2005) 2010-2017
20. Mohanraj R., and Brodie M.J. Outcomes in newly diagnosed localization-related epilepsies 7. Seizure 14 (2005) 318-323
21. Rainier S., Sher C., Reish O., Thomas D., and Fink J.K. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch. Neurol. 63 (2006) 445-447
22. Rhodes T.H., Lossin C., Vanoye C.G., Wang D.W., and George Jr. A.L. Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy 1. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11147-11152
23. Rodrigues-Pinguet N., Jia L., Li M., Figl A., Klaassen A., Truong A., Lester H.A., and Cohen B.N. Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian alpha4beta2 acetylcholine response 1. J. Physiol. 550 (2003) 11-26
24. Scalmani P., Rusconi R., Armatura E., Zara F., Avanzini G., Franceschetti S., and Mantegazza M. Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing benign familial neonatal-infantile seizures 1. J. Neurosci. 26 (2006) 10100-10109
25. Tateyama M., Liu H., Yang A.S., Cormier J.W., and Kass R.S. Structural effects of an LQT-3 mutation on heart Na+ channel gating 1. Biophys. J. 86 (2004) 1843-1851
26. Valdivia C.R., Ackerman M.J., Tester D.J., Wada T., McCormack J., Ye B., and Makielski J.C. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine 2. Cardiovasc. Res. 55 (2002) 279-289
27. Vanmolkot K.R., Babini E., de V.B., Stam A.H., Freilinger T., Terwindt G.M., Norris L., Haan J., Frants R.R., Ramadan N.M., Ferrari M.D., Pusch M., van den Maagdenberg A.M., and Dichgans M. The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online 2. Hum. Mutat. 28 (2007) 522
28. Wallace R.H., Hodgson B.L., Grinton B.E., Gardiner R.M., Robinson R., Rodriguez-Casero V., Sadleir L., Morgan J., Harkin L.A., Dibbens L.M., Yamamoto T., Andermann E., Mulley J.C., Berkovic S.F., and Scheffer I.E. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms 8. Neurology 61 (2003) 765-769
29. Wang D.W., VanDeCarr D., Ruben P.C., George Jr. A.L., and Bennett P.B. Functional consequences of a domain 1/S6 segment sodium channel mutation associated with painful congenital myotonia 8. FEBS Lett. 448 (1999) 231-234
30. Wang D.W., Yazawa K., George Jr. A.L., and Bennett P.B. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome 10. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 13200-13205
31. Weiss L.A., Escayg A., Kearney J.A., Trudeau M., MacDonald B.T., Mori M., Reichert J., Buxbaum J.D., and Meisler M.H. Sodium channels SCN1A, SCN2A and SCN3A in familial autism 1. Mol. Psychiatry 8 (2003) 186-194
32. Whitaker W.R., Faull R.L., Waldvogel H.J., Plumpton C.J., Emson P.C., and Clare J.J. Comparative distribution of voltage-gated sodium channel proteins in human brain. Brain Res. Mol. Brain Res. 88 (2001) 37-53
33. Yarov-Yarovoy V., Brown J., Sharp E.M., Clare J.J., Scheuer T., and Catterall W.A. Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J. Biol. Chem. 276 (2001) 20-27
34. Yoshinaga H., Hattori J., Ohta H., Asano T., Ogino T., Kobayashi K., and Oka E. Utility of the scalp-recorded ictal EEG in childhood epilepsy. Epilepsia 42 (2001) 772-777